Nicholas J Ashton

6PUBLICATIONS
16CO-AUTHORS
Memory and attentionAutonomic nervous systemPredictive and prognostic markersAutoimmunityCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 13, 2026
Circulating Metabolite Signatures Associated With Amyloid Positivity, Cognitive Performance and Plasma P-tau181 Levels in Cognitively Unimpaired Older Adults.

|May 09, 2026
Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer's Disease.

|Nov 02, 2021
P-tau235: a novel biomarker for staging preclinical Alzheimer's disease.

Juan Lantero-Rodriguez, Anniina Snellman, Andrea L Benedet

|Feb 15, 2021
Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.

Nicholas J Ashton, Tharick A Pascoal, Thomas K Karikari

|Nov 10, 2020
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected.

Marc Suárez-Calvet, Thomas K Karikari, Nicholas J Ashton

|Jul 29, 2020
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline.

Juan Lantero Rodriguez, Thomas K Karikari, Marc Suárez-Calvet

Pageof 1

Frequent Collaborators

4 joint publications

Kaj Blennow

2 joint publications

Marc Suárez-Calvet

2 joint publications

Ralph N Martins

2 joint publications

Manohar L Garg